Investors Alert: Reckitt Benckiser Group Faces Class Action Lawsuit Over Securities Fraud Allegations

Date: July 18, 2025
Source: Levi & Korsinsky, LLP

Investors in Reckitt Benckiser Group plc, a prominent player in health and hygiene products, have been put on notice by the law firm Levi & Korsinsky regarding a pending class action lawsuit. This legal action is on behalf of shareholders who may have incurred losses due to alleged securities fraud committed between January 13, 2021, and July 28, 2024. Shareholders are urged to act quickly, as the deadline to request the Court to appoint them as lead plaintiff is set for August 4, 2025.

Allegations Against Reckitt Benckiser

The core of the lawsuit centers around claims that Reckitt Benckiser misrepresented critical facts concerning its infant formula product, Enfamil. Allegations include that the company concealed the increased risks associated with cow's milk-based formulas, particularly for preterm infants, potentially leading to a serious condition known as necrotizing enterocolitis (NEC). The consequences of these misrepresented claims reportedly affected the company's sales and left it vulnerable to numerous legal claims.

Furthermore, the suit contends that Reckitt’s positive statements regarding its business performance, operational strategies, and future prospects lacked any reasonable foundation, misguiding investors about the company’s true market vulnerabilities.

What Investors Should Know

For those affected by these allegations, participation in the class action requires no out-of-pocket expenses. Eligible investors may be entitled to compensation without the necessity of upfront fees or costs. It is crucial to understand that even if individuals do not serve as lead plaintiffs, their rights to a recovery remain intact.

The law firm Levi & Korsinsky brings extensive experience in managing complex securities litigation, having secured hundreds of millions of dollars for aggrieved shareholders in the past. With over 70 dedicated professionals, the firm prides itself on providing knowledgeable assistance and advocacy in navigating the intricacies of such legal matters.

Next Steps for Investors

If you believe that you have incurred losses related to Reckitt Benckiser’s stock during the relevant period, it is critical to reach out to Levi & Korsinsky as soon as possible. You can contact attorney Joseph E. Levi via email at [email protected] or by phone at (212) 363-7500. Further details can also be found at their website, which outlines the class action submission process and provides additional resources.

This lawsuit underlines the importance of due diligence and awareness in investment decisions, particularly in the health and consumer goods sectors where product safety can dramatically affect a company’s financial standing.

As the legal proceedings unfold, it will be imperative for investors to stay informed about the developments in this case and any potential implications for their investments in Reckitt Benckiser Group plc.